Approximately half of patients with anti-MDA5 antibody-positive DM with ILD (MDA5+ DM-ILD) develop into rapidly progressive ILD (RP-ILD), which usually has a poor prognosis. The gene discussed is IFIH1; the disease is interstitial lung disease.